The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ambrisentan Drug Market Research Report 2025
Synopsis
Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension.
The global Ambrisentan Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ambrisentan Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ambrisentan Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ambrisentan Drug in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ambrisentan Drug include Gilead Sciences, GSK and Hansoh Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ambrisentan Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ambrisentan Drug.
Report Scope
The Ambrisentan Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ambrisentan Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ambrisentan Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
GSK
Hansoh Pharma
Segment by Type
5 mg Tablet
10 mg Tablet
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ambrisentan Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension.
The global Ambrisentan Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ambrisentan Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ambrisentan Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ambrisentan Drug in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ambrisentan Drug include Gilead Sciences, GSK and Hansoh Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ambrisentan Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ambrisentan Drug.
Report Scope
The Ambrisentan Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ambrisentan Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ambrisentan Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
GSK
Hansoh Pharma
Segment by Type
5 mg Tablet
10 mg Tablet
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ambrisentan Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ambrisentan Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 5 mg Tablet
1.2.3 10 mg Tablet
1.3 Market by Application
1.3.1 Global Ambrisentan Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ambrisentan Drug Market Perspective (2019-2030)
2.2 Ambrisentan Drug Growth Trends by Region
2.2.1 Global Ambrisentan Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ambrisentan Drug Historic Market Size by Region (2019-2024)
2.2.3 Ambrisentan Drug Forecasted Market Size by Region (2025-2030)
2.3 Ambrisentan Drug Market Dynamics
2.3.1 Ambrisentan Drug Industry Trends
2.3.2 Ambrisentan Drug Market Drivers
2.3.3 Ambrisentan Drug Market Challenges
2.3.4 Ambrisentan Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ambrisentan Drug Players by Revenue
3.1.1 Global Top Ambrisentan Drug Players by Revenue (2019-2024)
3.1.2 Global Ambrisentan Drug Revenue Market Share by Players (2019-2024)
3.2 Global Ambrisentan Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ambrisentan Drug Revenue
3.4 Global Ambrisentan Drug Market Concentration Ratio
3.4.1 Global Ambrisentan Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ambrisentan Drug Revenue in 2023
3.5 Ambrisentan Drug Key Players Head office and Area Served
3.6 Key Players Ambrisentan Drug Product Solution and Service
3.7 Date of Enter into Ambrisentan Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ambrisentan Drug Breakdown Data by Type
4.1 Global Ambrisentan Drug Historic Market Size by Type (2019-2024)
4.2 Global Ambrisentan Drug Forecasted Market Size by Type (2025-2030)
5 Ambrisentan Drug Breakdown Data by Application
5.1 Global Ambrisentan Drug Historic Market Size by Application (2019-2024)
5.2 Global Ambrisentan Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ambrisentan Drug Market Size (2019-2030)
6.2 North America Ambrisentan Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ambrisentan Drug Market Size by Country (2019-2024)
6.4 North America Ambrisentan Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ambrisentan Drug Market Size (2019-2030)
7.2 Europe Ambrisentan Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ambrisentan Drug Market Size by Country (2019-2024)
7.4 Europe Ambrisentan Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ambrisentan Drug Market Size (2019-2030)
8.2 Asia-Pacific Ambrisentan Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ambrisentan Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Ambrisentan Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ambrisentan Drug Market Size (2019-2030)
9.2 Latin America Ambrisentan Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ambrisentan Drug Market Size by Country (2019-2024)
9.4 Latin America Ambrisentan Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ambrisentan Drug Market Size (2019-2030)
10.2 Middle East & Africa Ambrisentan Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ambrisentan Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Ambrisentan Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Ambrisentan Drug Introduction
11.1.4 Gilead Sciences Revenue in Ambrisentan Drug Business (2019-2024)
11.1.5 Gilead Sciences Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Ambrisentan Drug Introduction
11.2.4 GSK Revenue in Ambrisentan Drug Business (2019-2024)
11.2.5 GSK Recent Development
11.3 Hansoh Pharma
11.3.1 Hansoh Pharma Company Detail
11.3.2 Hansoh Pharma Business Overview
11.3.3 Hansoh Pharma Ambrisentan Drug Introduction
11.3.4 Hansoh Pharma Revenue in Ambrisentan Drug Business (2019-2024)
11.3.5 Hansoh Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Ambrisentan Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 5 mg Tablet
Table 3. Key Players of 10 mg Tablet
Table 4. Global Ambrisentan Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Ambrisentan Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Ambrisentan Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Ambrisentan Drug Market Share by Region (2019-2024)
Table 8. Global Ambrisentan Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Ambrisentan Drug Market Share by Region (2025-2030)
Table 10. Ambrisentan Drug Market Trends
Table 11. Ambrisentan Drug Market Drivers
Table 12. Ambrisentan Drug Market Challenges
Table 13. Ambrisentan Drug Market Restraints
Table 14. Global Ambrisentan Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Ambrisentan Drug Market Share by Players (2019-2024)
Table 16. Global Top Ambrisentan Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ambrisentan Drug as of 2023)
Table 17. Ranking of Global Top Ambrisentan Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Ambrisentan Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ambrisentan Drug Product Solution and Service
Table 21. Date of Enter into Ambrisentan Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ambrisentan Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Ambrisentan Drug Revenue Market Share by Type (2019-2024)
Table 25. Global Ambrisentan Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Ambrisentan Drug Revenue Market Share by Type (2025-2030)
Table 27. Global Ambrisentan Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Ambrisentan Drug Revenue Market Share by Application (2019-2024)
Table 29. Global Ambrisentan Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Ambrisentan Drug Revenue Market Share by Application (2025-2030)
Table 31. North America Ambrisentan Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Ambrisentan Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Ambrisentan Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Ambrisentan Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Ambrisentan Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Ambrisentan Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Ambrisentan Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Ambrisentan Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Ambrisentan Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Ambrisentan Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Ambrisentan Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Ambrisentan Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Ambrisentan Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Ambrisentan Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Ambrisentan Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Gilead Sciences Company Detail
Table 47. Gilead Sciences Business Overview
Table 48. Gilead Sciences Ambrisentan Drug Product
Table 49. Gilead Sciences Revenue in Ambrisentan Drug Business (2019-2024) & (US$ Million)
Table 50. Gilead Sciences Recent Development
Table 51. GSK Company Detail
Table 52. GSK Business Overview
Table 53. GSK Ambrisentan Drug Product
Table 54. GSK Revenue in Ambrisentan Drug Business (2019-2024) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Hansoh Pharma Company Detail
Table 57. Hansoh Pharma Business Overview
Table 58. Hansoh Pharma Ambrisentan Drug Product
Table 59. Hansoh Pharma Revenue in Ambrisentan Drug Business (2019-2024) & (US$ Million)
Table 60. Hansoh Pharma Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ambrisentan Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Ambrisentan Drug Market Share by Type: 2023 VS 2030
Figure 3. 5 mg Tablet Features
Figure 4. 10 mg Tablet Features
Figure 5. Global Ambrisentan Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Ambrisentan Drug Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Drug store Case Studies
Figure 9. Ambrisentan Drug Report Years Considered
Figure 10. Global Ambrisentan Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Ambrisentan Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Ambrisentan Drug Market Share by Region: 2023 VS 2030
Figure 13. Global Ambrisentan Drug Market Share by Players in 2023
Figure 14. Global Top Ambrisentan Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ambrisentan Drug as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Ambrisentan Drug Revenue in 2023
Figure 16. North America Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Ambrisentan Drug Market Share by Country (2019-2030)
Figure 18. United States Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Ambrisentan Drug Market Share by Country (2019-2030)
Figure 22. Germany Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Ambrisentan Drug Market Share by Region (2019-2030)
Figure 30. China Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Ambrisentan Drug Market Share by Country (2019-2030)
Figure 38. Mexico Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Ambrisentan Drug Market Share by Country (2019-2030)
Figure 42. Turkey Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Ambrisentan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Gilead Sciences Revenue Growth Rate in Ambrisentan Drug Business (2019-2024)
Figure 45. GSK Revenue Growth Rate in Ambrisentan Drug Business (2019-2024)
Figure 46. Hansoh Pharma Revenue Growth Rate in Ambrisentan Drug Business (2019-2024)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
